Oppenheimer & Co. Inc. raised its stake in shares of Houlihan Lokey Inc (NYSE:HLI) by 56.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,801 shares of the financial services provider’s stock after buying an additional 2,828 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Houlihan Lokey were worth $351,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Marshall Wace LLP purchased a new position in Houlihan Lokey during the second quarter valued at $1,131,000. BB&T Securities LLC raised its stake in Houlihan Lokey by 22.2% during the second quarter. BB&T Securities LLC now owns 14,637 shares of the financial services provider’s stock valued at $749,000 after buying an additional 2,657 shares during the last quarter. Capital Fund Management S.A. purchased a new position in Houlihan Lokey during the second quarter valued at $246,000. Principal Financial Group Inc. raised its stake in Houlihan Lokey by 0.7% during the first quarter. Principal Financial Group Inc. now owns 262,907 shares of the financial services provider’s stock valued at $11,725,000 after buying an additional 1,874 shares during the last quarter. Finally, Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in Houlihan Lokey by 14.1% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 9,325 shares of the financial services provider’s stock valued at $478,000 after buying an additional 1,151 shares during the last quarter. Institutional investors and hedge funds own 51.25% of the company’s stock.
A number of research analysts have issued reports on HLI shares. Zacks Investment Research cut Houlihan Lokey from a “hold” rating to a “sell” rating in a research note on Monday, September 17th. JMP Securities lifted their price objective on Houlihan Lokey from $55.00 to $57.00 and gave the company a “market outperform” rating in a research note on Friday, July 27th. ValuEngine cut Houlihan Lokey from a “buy” rating to a “hold” rating in a research note on Friday, September 28th. UBS Group lowered their price objective on Houlihan Lokey from $57.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, October 8th. Finally, Sandler O’Neill reiterated a “hold” rating and set a $52.00 price objective on shares of Houlihan Lokey in a research note on Thursday, August 2nd. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $52.00.
In other Houlihan Lokey news, major shareholder Orix Hlhz Holding Llc sold 12,978 shares of Houlihan Lokey stock in a transaction on Monday, August 27th. The stock was sold at an average price of $48.02, for a total value of $623,203.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In the last three months, insiders sold 122,016 shares of company stock valued at $5,882,778. Corporate insiders own 80.50% of the company’s stock.
Houlihan Lokey stock opened at $41.79 on Friday. The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of 16.27, a price-to-earnings-growth ratio of 1.30 and a beta of 0.64. Houlihan Lokey Inc has a 12 month low of $38.85 and a 12 month high of $53.20. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.93 and a quick ratio of 0.92.
Houlihan Lokey (NYSE:HLI) last posted its earnings results on Thursday, October 25th. The financial services provider reported $0.70 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.08. The business had revenue of $274.99 million during the quarter, compared to analyst estimates of $239.68 million. Houlihan Lokey had a return on equity of 20.55% and a net margin of 16.97%. Equities research analysts forecast that Houlihan Lokey Inc will post 2.72 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 14th. Shareholders of record on Monday, December 3rd will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date is Friday, November 30th. Houlihan Lokey’s payout ratio is 45.19%.
COPYRIGHT VIOLATION NOTICE: “Houlihan Lokey Inc (HLI) Shares Bought by Oppenheimer & Co. Inc.” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/11/10/houlihan-lokey-inc-hli-shares-bought-by-oppenheimer-co-inc.html.
Houlihan Lokey Company Profile
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), financing, financial restructuring, and financial advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial Advisory Services. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions.
Featured Article: Initial Public Offering (IPO)
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey Inc (NYSE:HLI).
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.